Article Versions Notes

Ahmed H, Gisler L, Elghazawy NH, Keller C, Sippl W, Liang SH, Haider A, Ametamey SM. Development and Validation of [³H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs. Pharmaceuticals. 2022; 15(8):960. https://doi.org/10.3390/ph15080960

Ahmed, Hazem, Livio Gisler, Nehal H. Elghazawy, Claudia Keller, Wolfgang Sippl, Steven H. Liang, Achi Haider, and Simon M. Ametamey. 2022. "Development and Validation of [³H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs" Pharmaceuticals 15, no. 8: 960. https://doi.org/10.3390/ph15080960

Ahmed, H., Gisler, L., Elghazawy, N. H., Keller, C., Sippl, W., Liang, S. H., Haider, A., & Ametamey, S. M. (2022). Development and Validation of [³H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs. Pharmaceuticals, 15(8), 960. https://doi.org/10.3390/ph15080960